Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Ovarian follicles

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    66 result(s) found for: Ovarian follicles. Displaying page 1 of 4.
    1  2  3  4  Next»
    EudraCT Number: 2019-000971-17 Sponsor Protocol Number: 58335 Start Date*: 2019-07-17
    Sponsor Name:UZ Brussel
    Full Title: Double trigger and ovum retrieval vs. conventional antagonist ovarian stimulation protocol in poor prognosis women undergoing IVF/ICSI: A pilot study
    Medical condition: infertility
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-000247-32 Sponsor Protocol Number: MAXINOVO Start Date*: 2020-11-03
    Sponsor Name:REPRODUCCION BILBAO (GINEGORAMA SL)
    Full Title: ACTIVATION OF PRIMORDIAL FOLLICULES AMONG WOMEN WITH POOR OVARIAN RESERVE BY USIN GROWTH FACTORS.
    Medical condition: The reproductive capacity of women depends on two factors: the number of follicles in the ovaries and the quality of oocytes within those follicles. Premature ovarian failure (POF) and poor ovaria...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-000500-13 Sponsor Protocol Number: 8821 Start Date*: 2005-08-15
    Sponsor Name:University of Oxford- Research Services
    Full Title: Metformin treatment before IVF in women with ultrasound evidence of polycystic ovaries; a prospective, randomised, double blind, placebo controlled study
    Medical condition: Infertile women undergoing IVF with sonographic evidence of polycystic ovaries but without any clinical manifestations of polycystic ovarian syndrome.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2012-004969-40 Sponsor Protocol Number: RHFERAMH-0001 Start Date*: 2012-11-27
    Sponsor Name:Fertility Clinic, Copenhagen University Hospital, Rigshospitalet
    Full Title: An AMH based indivdualised controlled ovarian stimulation regiment using Corifollitrophin or graded doses of rFSH versus a standard protocol. A randomised controlled trial
    Medical condition: In vitro fertilization include controlled ovarian stimulation (COS), where follicles are stimulated to full maturity. One of the main problems of the IVF treatment is still to some patients deve...
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004872 10021930 Infertility NOS LLT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2017-002571-25 Sponsor Protocol Number: 2017.corifollitropinalfa_IVM Start Date*: 2017-10-18
    Sponsor Name:UZ Brussel
    Full Title: A comparison between corifollitropin alfa and recombinant FSH for follicular recruitment in women with polycystic ovaries who undergo IVM treatment
    Medical condition: Infertile patients with polycystic ovaries
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000019245 10065161 Polycystic ovarian syndrome LLT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-003481-34 Sponsor Protocol Number: indvFSH2006 Start Date*: 2006-08-04
    Sponsor Name:Fertilitetsklinikken 4071, Rigshospitalet
    Full Title: Individuel versus standard rFSH dosis til kontrolleret ovariel stimulation og intrauterin insemination Et prospektivt randomiseret multicenter studie
    Medical condition: Ovulatory women suffering from infertility
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2016-005208-24 Sponsor Protocol Number: hCG-GR-001-2016 Start Date*: 2017-07-12
    Sponsor Name:Prof. Harry Siristatidis
    Full Title: A prospective, multicenter, double-blind, randomized, placebo-controlled, two-parallel groups Phase IIIb clinical study, to assess the efficacy and safety of adding low doses of hCG at a short IVF ...
    Medical condition: Infertility
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10021928 Infertility female PT
    Population Age: Adults Gender: Female
    Trial protocol: GR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-003104-11 Sponsor Protocol Number: 1.0 Start Date*: 2005-10-11
    Sponsor Name:Fertility clinic Odense University Hospital
    Full Title: Androgen priming in the late luteal phase as a mean to improve the outcome of ovarian stimulation for IVF in normogonadotrophic women with a previously proven poor response
    Medical condition: Hypothesis. By combining pituitary downregulation with aromatase inhibitor, and hCG injection during a late luteal phase a powerful stimulation of thecal androgen production is achieved. Thereby, i...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-001809-40 Sponsor Protocol Number: MER001 Start Date*: 2015-09-10
    Sponsor Name:IDIPAZ
    Full Title: Scheduling of GnRH antagonist FIV-ICSI cycles with estrogen or contraceptive oral pills in previous luteal phase. Comparison of results against no treatment.
    Medical condition: Sterility
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004872 10042012 Sterility LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: View results
    EudraCT Number: 2014-003986-11 Sponsor Protocol Number: 1401-MAD-004-IO Start Date*: 2016-10-22
    Sponsor Name:IVI Madrid
    Full Title: Prospective, double-blinded, randomized clinical trial to evaluate the potential benefitial effect of resveratrol for preventing the ovarian hyperstimulation syndrome.
    Medical condition: Resveratrol may prevent the incidence of ovarian hyperstimulation syndrome by reducing the expression of VEGF and estradiol, improving the haemoconcentration and ascitis Re
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-002341-30 Sponsor Protocol Number: 1705-VLC-030-JG Start Date*: 2017-09-11
    Sponsor Name:INSTITUTO VALENCIANO DE INFERTILIDAD (IVI)
    Full Title: Usefulness of medroxyprogesterone acetate in the follicular phase for ovarian donors to prevent premature luteinization
    Medical condition: prevent premature luteinitation
    Disease: Version SOC Term Classification Code Term Level
    20.0 10041244 - Social circumstances 10072070 Oocyte donor PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2013-003817-16 Sponsor Protocol Number: EMR200061-005 Start Date*: 2014-02-05
    Sponsor Name:Merck KGaA
    Full Title: A phase III, randomized, controlled, single-blind, multicentre, parallel arm trial to assess the efficacy and safety of Pergoveris® (follitropin alfa and lutropin alfa) and GONAL-f® (follitropin...
    Medical condition: Poor Ovarian Response i.e. a failure to respond adequately to standard ART (assisted reproductive technologies) protocols and to recruit adequate follicles
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004872 10033140 Ovarian disorder NOS LLT
    Population Age: Adults Gender: Female
    Trial protocol: CZ (Completed) SE (Completed) EE (Completed) HU (Completed) BE (Completed) GB (Completed) NL (Completed) DK (Completed) LV (Completed) ES (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2013-001616-30 Sponsor Protocol Number: 000071 Start Date*: 2013-09-17
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A controlled, assessor-blind, parallel groups, multicentre, multinational trial evaluating the immunogenicity of FE 999049 in repeated cycles of controlled ovarian stimulation in women undergoing a...
    Medical condition: Infertility
    Disease: Version SOC Term Classification Code Term Level
    16.0 10038604 - Reproductive system and breast disorders 10021926 Infertility PT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed) GB (Completed) CZ (Completed) DK (Completed) ES (Completed) PL (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2022-002310-16 Sponsor Protocol Number: LHinPOR001 Start Date*: 2023-02-01
    Sponsor Name:UZ Brussel
    Full Title: Endometrial gene expression profiles during ovarian stimulation with recombinant human FSH with or without the addition of recombinant human LH in genuine poor responders.
    Medical condition: Infertility
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-005099-27 Sponsor Protocol Number: IIBSP-FOS-2014-67 Start Date*: 2015-05-18
    Sponsor Name:Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau ? IIB Sant Pau
    Full Title: randomized, single blind, prospective clinical study to compare hFSH-HP (Fostipur) and hMG-HP (Menopur) in patients with polycystic ovary ander a FIV/ICSI cicle.
    Medical condition: women with polycystic ovary under a cicle of FIV/ICSI.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2015-005660-42 Sponsor Protocol Number: IIBSP-FOS-2016-01 Start Date*: 2016-03-31
    Sponsor Name:Institut de Recerca HSCSP
    Full Title: Randomized, single blind, prospective clinical study to compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in patients with polycystic ovary under a FIV/ICSI cicle.
    Medical condition: Women with polycystic ovary under a cicle of FIV/ICSI.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2020-002453-26 Sponsor Protocol Number: 73908 Start Date*: 2020-11-18
    Sponsor Name:Rigshospitalet
    Full Title: Eight weeks of androgen priming by hCG before IVF/ICSI in women with low ovarian reserve.
    Medical condition: Female Infertility
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004872 10016399 Female infertility (primary) LLT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2006-003812-23 Sponsor Protocol Number: 107014 Start Date*: 2006-12-21
    Sponsor Name:NV Organon
    Full Title: Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 107012 for the development of Org 36286 (corifollitropin alfa)
    Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed) AT (Completed) CZ (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2009-012847-40 Sponsor Protocol Number: Pergoveris_Cetrorelix_1 Start Date*: 2009-11-11
    Sponsor Name:NHS Lothian [...]
    1. NHS Lothian
    2. The University of Edinburgh
    Full Title: A Randomised Study Comparing Two Different Regimens of Ovarian Stimulation Using Pergoveris and Cetrorelix for Controlled Ovarian Superovulation in Assisted Conception Treatment.
    Medical condition: Subfertility
    Disease: Version SOC Term Classification Code Term Level
    12. 10042391 Subfertility LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-000415-15 Sponsor Protocol Number: FE 999051 CS01 Start Date*: 2006-05-25
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: EQUIPO (Efecto de Quinagolida en la Prevención de OHSS) Estudio de prueba de hipótesis, aleatorizado, doble ciego, de grupos paralelos, en búsqueda de dosis, controlado con placebo, multicéntrico,...
    Medical condition: Síndrome de hiperestimulación ovárica en mujeres con hiperestimulación ovárica controlada en técnicas de reproducción asistida
    Disease: Version SOC Term Classification Code Term Level
    8.1 10033266 PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 11 23:42:59 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA